| MS cases n (%) | ORXY (95%CI)1 | P | T2D cases n (%) | ORXY (95%CI) 2 | P |
---|---|---|---|---|---|---|
Every decreasing 10 nmol/L 25(OH)D | 746(31.17) | 1.10(1.02–1.23) | 0.027* | 361(15.09) | 1.07(1.01–1.21) | 0.018* |
Adj-R2 | Â | 0.732 | Â | Â | 0.756 | Â |
Every decreasing 25 nmol/L 25(OH)D |  | 1.23(1.06–1.52) | 0.002* |  | 1.14(1.05–1.33) | 0.001* |
Adj-R2 | Â | 0.789 | Â | Â | 0.764 | Â |
Quintiles of 25(OH) D (nmol/L) | ||||||
 Q1(≥57.5) | 135(26.68) | 1.00 |  | 53(11.08) | 1.00 |  |
 Q2(46.0–57.4) | 129(28.48) | 1.09(1.01–1.45) | 0.025* | 64(13.77) | 1.12(1.03–1.59) | 0.004* |
 Q3((36.8–45.9) | 161(31.69) | 1.29(1.03–1.75) | < 0.001* | 75(15.14) | 1.33(1.05–1.67) | < 0.001* |
 Q4(28.5–36.7) | 167(34.08) | 1.47(1.17–1.81) | < 0.001* | 82(17.13) | 1.50(1.17–1.82) | < 0.001* |
 Q5(< 28.4) | 154(35.32) | 1.55(1.24–1.89) | < 0.001* | 87(18.29) | 1.53(1.21–1.87) | < 0.001* |
Adj-R2 | Â | 0.784 | Â | Â | 0.753 | Â |
Clinical categories of 25(OH) D (nmol/L) | ||||||
  ≥ 75 | 21(26.12) | 1.00 |  | 10(12.44) | 1.00 |  |
 50–75 | 196(27.90) | 1.30(1.06–1.61) | 0.008* | 92(13.08) | 1.32(1.08–1.64) | 0.001* |
 25–50 | 390(31.90) | 1.50(1.24–1.79) | < 0.001* | 188(15.41) | 1.47(1.12–1.80) | < 0.001* |
  < 25 | 139(35.91) | 1.52(1.29–1.85) | < 0.001* | 71(18.25) | 1.54(1.27–1.85) | < 0.001* |
Adj-R2 | Â | 0.713 | Â | Â | 0.762 | Â |